Luigi Solbiati
Papers
1
Total Citations
30
H-Index
1
About
Dr. Luigi Solbiati is a pioneering figure in interventional oncology, renowned for his groundbreaking work in the non-invasive treatment of liver tumors. His research centers on the development and clinical validation of histotripsy, a novel, non-thermal focused ultrasound technique that mechanically liquefies targeted tissue without incisions or radiation. As the lead investigator of the landmark #HOPE4LIVER single-arm pivotal trial, Dr. Solbiati has demonstrated the safety and 1-year efficacy of hepatic histotripsy for both primary and metastatic liver tumors, a study that has already garnered 30 citations since its 2025 publication. This work represents a paradigm shift in tumor ablation, offering a precise, incision-free alternative to thermal methods. Beyond this trial, his extensive portfolio—encompassing radiofrequency ablation and contrast-enhanced ultrasound—has shaped modern liver cancer management. With a career spanning decades and thousands of citations, Dr. Solbiati’s contributions have established him as a global authority in image-guided therapies, consistently pushing the boundaries of what is possible in non-surgical tumor destruction.
Research Focus
Key Achievements
Top Papers
- 1